Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Correlation of B-type natriuretic peptide levels and echocardiographic parameters in preterm infants with patent ductus arteriosus

  • Jeong, Hyun Ah (Department of Pediatrics, Korea University College of Medicine) ;
  • Shin, Jeonghee (Department of Pediatrics, Korea University College of Medicine) ;
  • Kim, Eunji (Department of Pediatrics, Korea University College of Medicine) ;
  • Lee, Eun Hee (Department of Pediatrics, Korea University College of Medicine) ;
  • Choi, Byung Min (Department of Pediatrics, Korea University College of Medicine) ;
  • Son, Chang Sung (Department of Pediatrics, Korea University College of Medicine) ;
  • Lee, Joo Won (Department of Pediatrics, Korea University College of Medicine)
  • 투고 : 2015.09.14
  • 심사 : 2015.11.05
  • 발행 : 2016.04.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study aimed to evaluate the correlation, according to postnatal age, between plasma B-type natriuretic peptide (BNP) levels and echocardiographic parameters for the assessment of patent ductus arteriosus (PDA) in preterm infants with respiratory distress. Methods: We enrolled 42 preterm infants with respiratory distress who underwent serial echocardiographic evaluation with simultaneous plasma BNP measurements until ductal closure. The correlations between BNP levels and the following 4 representative echocardiographic parameters were studied: diameter of the ductus arteriosus (DA), ratio of the left atrial diameter to the aortic diameter (LA/Ao), ratio of the PDA diameter to the infant's left pulmonary artery diameter (PDA/LPA), and the antegrade diastolic flow of LPA (DFLPA). Results: BNP levels were significantly correlated to the magnitude of the ductal shunt, comprising the DA diameter, PDA/LPA ratio, LA/Ao ratio, and antegrade DFLPA for the overall study period. The earliest significant correlation, starting from postnatal day 2, was observed between the LA/Ao ratio and BNP levels. The PDA/LPA ratio and the antegrade DFLPA showed significant correlations with BNP levels postnatal day 3 onward, and with the DA diameter, postnatal day 5 onward. Conclusion: BNP levels and echocardiographic parameters showed a positive correlation, but the significance of the correlations differed according to the postnatal age, especially during the first few days of life.

키워드

참고문헌

  1. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000;137:68-72. https://doi.org/10.1067/mpd.2000.106569
  2. Shortland DB, Gibson NA, Levene MI, Archer LN, Evans DH, Shaw DE. Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol 1990;32:386-93.
  3. Maruyama K, Koizumi T, Tomomasa T, Morikawa A. Intestinal blood-flow velocity in uncomplicated preterm infants during the early neonatal period. Pediatr Radiol 1999;29:472-7. https://doi.org/10.1007/s002470050621
  4. Shimada S, Kasai T, Konishi M, Fujiwara T. Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr 1994;125:270-7. https://doi.org/10.1016/S0022-3476(94)70210-1
  5. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183-6. https://doi.org/10.1136/fn.75.3.F183
  6. Ryder RW, Shelton JD, Guinan ME. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980;112: 113-23. https://doi.org/10.1093/oxfordjournals.aje.a112960
  7. Nash PL. Brain type natriuretic peptide. Neonatal Netw 2008;27: 343-6. https://doi.org/10.1891/0730-0832.27.5.343
  8. Das BB, Raj S, Solinger R. Natriuretic peptides in cardiovascular diseases of fetus, infants and children. Cardiovasc Hematol Agents Med Chem 2009;7:43-51. https://doi.org/10.2174/187152509787047667
  9. El-Khuffash A, Molloy EJ. Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch Dis Child Fetal Neonatal Ed 2007;92:F320-4. https://doi.org/10.1136/adc.2006.106039
  10. Lee HS, Choi WS, Choi BM, Lee KH, Eun BL, Yoo KH, et al. Usefulness of B-type natriuretic peptide assay in predicting symptomatic patent ductus arteriosus in preterm infants. J Korean Soc Neonatol 2004;11:44-53.
  11. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005;115:e255-61. https://doi.org/10.1542/peds.2004-1837
  12. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005;147:38-42. https://doi.org/10.1016/j.jpeds.2005.03.040
  13. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006;27:861-6. https://doi.org/10.1093/eurheartj/ehi773
  14. Hsu JH, Yang SN, Chen HL, Tseng HI, Dai ZK, Wu JR. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr 2010;157:79-84. https://doi.org/10.1016/j.jpeds.2009.12.045
  15. Kim JS, Shim EJ. B-type natriuretic peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants. Korean Circ J 2012;42:192-6. https://doi.org/10.4070/kcj.2012.42.3.192
  16. Lee JH, Shin JH, Park KH, Rhie YJ, Park MS, Choi BM. Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants? Neonatology 2013;103:118-22. https://doi.org/10.1159/000343034
  17. Kulkarni M, Gokulakrishnan G, Price J, Fernandes CJ, Leeflang M, Pammi M. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review. Pediatrics 2015;135:e510-25. https://doi.org/10.1542/peds.2014-1995
  18. Lee EH, Choi BM. Clinical applications of plasma B-type natriuretic peptide assays in preterm infants with patent ductus arteriosus. Neonatal Med 2013;20:323-34. https://doi.org/10.5385/nm.2013.20.3.323
  19. El-Khuffash AF, McNamara PJ. Neonatologist-performed functional echocardiography in the neonatal intensive care unit. Semin Fetal Neonatal Med 2011;16:50-60. https://doi.org/10.1016/j.siny.2010.05.001
  20. Mertens L, Seri I, Marek J, Arlettaz R, Barker P, McNamara P, et al. Targeted Neonatal Echocardiography in the Neonatal Intensive Care Unit: practice guidelines and recommendations for training. Writing Group of the American Society of Echocardiography (ASE) in collaboration with the European Association of Echocardiography (EAE) and the Association for European Pediatric Cardiologists (AEPC). J Am Soc Echocardiogr 2011;24: 1057-78. https://doi.org/10.1016/j.echo.2011.07.014
  21. Evans N. Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants. Adv Neonatal Care 2003;3:168-77. https://doi.org/10.1016/S1536-0903(03)00143-7
  22. Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound? Semin Perinatol 2012;36:114-22. https://doi.org/10.1053/j.semperi.2011.09.021
  23. Chen S, Tacy T, Clyman R. How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? J Perinatol 2010;30:780-5. https://doi.org/10.1038/jp.2010.47
  24. Evans N, Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995; 72:F156-61. https://doi.org/10.1136/fn.72.3.F156
  25. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-9. https://doi.org/10.1016/S0022-3476(95)70172-9
  26. Sehgal A, McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr 2009;168:907-14. https://doi.org/10.1007/s00431-009-0983-3
  27. Czernik C, Lemmer J, Metze B, Koehne PS, Mueller C, Obladen M. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008;64:286-90. https://doi.org/10.1203/PDR.0b013e3181799594
  28. Wald RM, Adatia I, Van Arsdell GS, Hornberger LK. Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly. Am J Cardiol 2005;96:851-6. https://doi.org/10.1016/j.amjcard.2005.05.035
  29. Ramos FG, Rosenfeld CR, Roy L, Koch J, Ramaciotti C. Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates. J Perinatol 2010; 30:535-9. https://doi.org/10.1038/jp.2010.14
  30. Iyer P, Evans N. Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 1994;70:F112-7. https://doi.org/10.1136/fn.70.2.F112
  31. Wilson N, Dickinson DF, Goldberg SJ, Scott O. Pulmonary artery velocity patterns in ductus arteriosus. Br Heart J 1984;52:462-4. https://doi.org/10.1136/hrt.52.4.462
  32. Hiraishi S, Horiguchi Y, Misawa H, Oguchi K, Kadoi N, Fujino N, et al. Noninvasive Doppler echocardiographic evaluation of shunt flow dynamics of the ductus arteriosus. Circulation 1987;75:1146-53. https://doi.org/10.1161/01.CIR.75.6.1146
  33. Hirsimaki H, Kero P, Wanne O. Doppler ultrasound and clinical evaluation in detection and grading of patient ductus arteriosus in neonates. Crit Care Med 1990;18:490-3. https://doi.org/10.1097/00003246-199005000-00005
  34. Suzumura H, Nitta A, Tanaka G, Arisaka O. Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int 2001;43:146-51. https://doi.org/10.1046/j.1442-200x.2001.01365.x

피인용 문헌

  1. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arterios vol.32, pp.1, 2016, https://doi.org/10.3346/jkms.2017.32.1.115
  2. Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants vol.60, pp.6, 2017, https://doi.org/10.3345/kjp.2017.60.6.175
  3. B-type natriuretic peptide may have a role in the management of patent ductus arteriosus vol.61, pp.2, 2016, https://doi.org/10.3345/kjp.2018.61.2.68
  4. Effectiveness of B-type Natriuretic Peptide in Caring for Preterm Infants vol.29, pp.2, 2018, https://doi.org/10.14734/pn.2018.29.2.78
  5. The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct vol.18, pp.1, 2019, https://doi.org/10.15690/vsp.v18i1.1987
  6. Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes vol.62, pp.7, 2016, https://doi.org/10.3345/kjp.2018.07213
  7. Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation vol.19, pp.1, 2019, https://doi.org/10.1186/s12887-019-1708-z
  8. Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus vol.10, pp.None, 2016, https://doi.org/10.1038/s41598-020-61291-w
  9. Application of B-Type Natriuretic Peptide in Neonatal Diseases vol.9, pp.None, 2016, https://doi.org/10.3389/fped.2021.767173